Updates in Ophthalmic Oncology


Duangnate Rojanaporn, M.D.

Department of Ophthalmology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand


The current population of Thailand is approximately 69 million (United Nations estimates). According to the nationwide multicenter population-based prospective study of the incidence and survival rate of childhood cancer from Thai Pediatric Oncology Group (ThaiPOG), there were 97 cases of retinoblastoma diagnosed during the year 2003-2005, placing retinoblastoma the 7th most common childhood cancer in Thailand, with the incidence of 3.1 per million population with overall survival probability at 5 years of 73%. The predicted incidence of retinoblastoma in Thailand, calculated from 67 million population, is 41 children in 2013 and 2023. The treatment modalities and survival rate of retinoblastoma in Thailand varies among each center and region of the country. 

A multi-center study and national system of retinoblastoma registration are required to establish a nationwide picture of this disease. Education of public and primary health care providers, along with the implementation of a retinoblastoma screening program, should be promoted to enable earlier detection of retinoblastoma. This would allow patients to gain better treatment outcomes. In addition, proper retinoblastoma management necessitates multidisciplinary cooperation, by a team that should include an ocular oncologist, pediatric oncologist, neurointerventionist, and ocular pathologist. As such specialized providers are not available in many areas of the country, comprehensive referral centers may present one solution toward better provision of retinoblastoma care in Thailand.


Professor Wasee Tulvatana, MD, MSc

Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand


Retinoblastoma is the most common primary intraocular malignancy in children worldwide. The diagnosis mainly relies on pathology results. In this meeting session, we describe the basic gross and microscopic pathology of this tumor. Recent pathology classification and advanced techniques regarding the prognostic indicators of tumor local recurrence and distant metastasis will be discussed.

Event Hours(1)

  • Lotus 1-2.

    03:00 pm – 04:30 pm

    1. Dr. Duangnate Rojanaporn (Rama)
    2. Prof. La-ongsri Atchaneeyasakul (SI)
    3. Dr. Pornpattana Vichitvejpaisal (CRA)
    4. Prof. Wasee Tulvatana (CU)

    Prof. Suradej Hongeng (Rama)